Clinical Trials Directory

Trials / Unknown

UnknownNCT05094492

Evaluation of Remineralization Potential of Self Assembling Peptide Combined With Fluoride

Evaluation of Remineralization Potential of Self Assembling Peptide P11-4 Combined With Fluoride Compared to Fluoride Varnish in Management of Incipient Carious Lesions Using Laser Fluorescence: Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
58 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Not accepted

Summary

Self-assembling peptide (P11-4) exhibited an outstanding ability for biomimetic re-mineralization of incipient enamel carious lesions. It creates a 3D matrix within the subsurface of carious lesions, allowing de novo formation of Hydroxyapatite crystals, thus enabling guided enamel regeneration of the demineralized enamel structure. Addition of fluoride to P11-4 may have a synergistic effect on the remineralization potential.

Detailed description

This study is a randomized clinical trial, with parallel study design, 1:1 allocation ratio and superiority framework. The aim of the current trial is to evaluate remineralization potential of P11-4 combined with fluoride compared to fluoride varnish in management of incipient white spot carious lesions. Progress of the lesions will be assessed using laser fluorescence (DIAGNOdent).

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTCurodont Repair Fluoride PlusP11-4 self assembling peptide combined with fluoride
OTHERBifluorid 10 fluoride varnish5% Sodium Fluoride varnish (equal to 22,600 ppm fluoride)

Timeline

Start date
2021-10-30
Primary completion
2022-04-30
Completion
2022-06-30
First posted
2021-10-26
Last updated
2021-10-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05094492. Inclusion in this directory is not an endorsement.